NXGN Stock Overview NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. More details
Rewards Risk Analysis No risks detected for NXGN from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
NextGen Healthcare, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for NextGen Healthcare Historical stock prices Current Share Price US$23.94 52 Week High US$23.98 52 Week Low US$15.23 Beta 0.77 1 Month Change 0.46% 3 Month Change 41.66% 1 Year Change 19.28% 3 Year Change 52.97% 5 Year Change 51.04% Change since IPO 13,828.73%
Recent News & Updates
NextGen Healthcare Introduces AI-Driven Ambient Listening Innovation for Ophthalmologists and Optometrists Oct 02
NextGen Healthcare Expands Capabilities of NextGen®? Ambient Assist and Introduces Tailored Solution for Small Practices, NextGen®? Office Ambient Assist Jun 24
NextGen Healthcare, Inc. Bolsters C-Suite with Three Industry Veterans May 09
NextGen Healthcare Launches Ai-Driven Efficiency Solution for Mental and Behavioral Health Professionals Apr 11
NextGen Healthcare, Inc. Files Form 15 Nov 22 Thoma Bravo Discover Fund IV, managed by Thoma Bravo, L.P. completed the acquisition of NextGen Healthcare, Inc. (NasdaqGS:NXGN) from shareholders. See more updates
NextGen Healthcare Introduces AI-Driven Ambient Listening Innovation for Ophthalmologists and Optometrists Oct 02
NextGen Healthcare Expands Capabilities of NextGen®? Ambient Assist and Introduces Tailored Solution for Small Practices, NextGen®? Office Ambient Assist Jun 24
NextGen Healthcare, Inc. Bolsters C-Suite with Three Industry Veterans May 09
NextGen Healthcare Launches Ai-Driven Efficiency Solution for Mental and Behavioral Health Professionals Apr 11
NextGen Healthcare, Inc. Files Form 15 Nov 22 Thoma Bravo Discover Fund IV, managed by Thoma Bravo, L.P. completed the acquisition of NextGen Healthcare, Inc. (NasdaqGS:NXGN) from shareholders.
NextGen Healthcare, Inc. Unveils NextGen Ambient Assist, an AI Solution Designed to Boost Provider Efficiency Oct 10 Thoma Bravo Discover Fund IV, managed by Thoma Bravo, L.P. entered into a definitive agreement to acquire NextGen Healthcare, Inc. (NasdaqGS:NXGN) from shareholders for $1.6 billion.
Price target increased by 7.0% to US$21.68 Sep 06
Thoma Bravo Reportedly in Advanced Talks to Buy NextGen Healthcare Sep 06
NextGen Healthcare Reportedly Explores Sale Aug 24
Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 49% Undervaluation? Aug 24
NextGen Healthcare, Inc., Annual General Meeting, Aug 22, 2023 Jul 29
NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next Jul 27
First quarter 2024 earnings: EPS and revenues exceed analyst expectations Jul 25
NextGen Healthcare, Inc. Revises Financial Guidance for the Fiscal Year 2024 Jul 25
NextGen Healthcare, Inc. Enters into Settlement Agreement with the U.S. Department of Justice and Two Private Parties Jul 15
Investors Will Want NextGen Healthcare's (NASDAQ:NXGN) Growth In ROCE To Persist Jul 13
NextGen Healthcare, Inc. to Report Q1, 2024 Results on Jul 24, 2023 Jul 12
We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease Jun 08
Price target decreased by 8.0% to US$20.25 May 24
Calculating The Fair Value Of NextGen Healthcare, Inc. (NASDAQ:NXGN) May 19
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind May 18
NextGen Healthcare, Inc. Provides Revenue Guidance for the Fiscal Year 2024 May 17
What Does NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Share Price Indicate? Mar 14
We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease Feb 27
NextGen Healthcare, Inc. Announces Resignation of David A. Metcalfe as Executive Vice President & Chief Technology Officer Feb 08
Consensus EPS estimates increase by 88% Feb 01
Third quarter 2023 earnings: EPS exceeds analyst expectations Jan 26
NextGen Healthcare, Inc. Revises Earnings Guidance for the Year 2023 Jan 25
NextGen Healthcare, Inc. to Report Q3, 2023 Results on Jan 24, 2023 Jan 18
Now 21% undervalued Jan 05
Executive VP & CFO exercised options and sold US$533k worth of stock Dec 29
Is NextGen Healthcare, Inc. (NASDAQ:NXGN) Expensive For A Reason? A Look At Its Intrinsic Value Dec 08
Consensus forecasts updated Dec 08
Executive VP & CTO exercised options and sold US$132k worth of stock Dec 03
NextGen Healthcare, Inc. (NasdaqGS:NXGN) acquired TSI Healthcare, Inc. for $90 million. Dec 02
NextGen Healthcare, Inc. (NasdaqGS:NXGN) acquired TSI Healthcare, Inc. for $90 million. Dec 01
Executive VP & CTO exercised options and sold US$194k worth of stock Oct 29
These Return Metrics Don't Make NextGen Healthcare (NASDAQ:NXGN) Look Too Strong Oct 27
NextGen Healthcare, Inc. Revises Earnings Guidance for the Fiscal Year 2023 Oct 27
Second quarter 2023 earnings: EPS and revenues exceed analyst expectations Oct 26
NextGen Healthcare, Inc. (NasdaqGS:NXGN) announces an Equity Buyback for $100 million worth of its shares. Oct 26
NextGen Healthcare, Inc. to Report Q2, 2023 Results on Oct 25, 2022 Oct 18
At US$17.85, Is It Time To Put NextGen Healthcare, Inc. (NASDAQ:NXGN) On Your Watch List? Sep 30
CEO, President & Director exercised options and sold US$414k worth of stock Sep 28
NextGen Enterprise solution to be used by NY-based health center Sep 28
NextGen Healthcare, Inc Announces New Foster Care Functionality in Behavioral Health Suite Sep 15
NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Intrinsic Value Is Potentially 75% Above Its Share Price Sep 07
Planet DDS, Inc. acquired NXGN Management LLC from NextGen Healthcare, Inc. (NasdaqGS:NXGN). Aug 12
NextGen Healthcare (NASDAQ:NXGN) Is Finding It Tricky To Allocate Its Capital Jul 29
NextGen Healthcare, Inc. Revises Earnings Guidance for the Year 2023 Jul 27
First quarter 2023 earnings: EPS exceeds analyst expectations Jul 27
NextGen Healthcare Non-GAAP EPS of $0.16 in-line, revenue of $153.3M in-line, 2023 revenue outlook below estimates Jul 26
NextGen Healthcare, Inc. to Report Q1, 2023 Results on Jul 26, 2022 Jul 13
Independent Vice Chairman notifies of intention to sell stock Jul 08
NextGen Healthcare, Inc., Annual General Meeting, Aug 17, 2022 Jun 23
NextGen Healthcare, Inc. Launches Health Data Hub Insights May 28
Consensus forecasts updated May 25
Full year 2022 earnings: EPS misses analyst expectations May 18
NextGen Healthcare, Inc. Provides Earnings Guidance for the Fiscal Year 2023 May 18
Is It Too Late To Consider Buying NextGen Healthcare, Inc. (NASDAQ:NXGN)? May 17
NextGen Healthcare, Inc. Provides Preliminary Unaudited Earnings Guidance for the Fourth Quarter and Full Year Ended March 31, 2022 and for the Fiscal Year 2023 May 05
Consensus forecasts updated May 04
Executive VP & CTO exercised options and sold US$200k worth of stock Apr 27
Nextgen Healthcare Releases Latest EHR Tool for Behavioral Health, Human Services Apr 19
Independent Vice Chairman notifies of intention to sell stock Apr 07
NextGen Healthcare Unveils Latest Solution for Behavioral Health and Human Services Apr 01
Insider exercised options and sold US$315k worth of stock Mar 06
Consensus forecasts updated Feb 06
Consensus forecasts updated Feb 02
Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Jan 27
NextGen Healthcare, Inc. Raises Revenue Guidance for Fiscal Year 2022 Jan 26
CEO, President & Director recently bought US$101k worth of stock Dec 01
Independent Vice Chairman notifies of intention to sell stock Nov 06
Second quarter 2022 earnings released: US$0.10 loss per share (vs US$0.16 profit in 2Q 2021) Oct 30
NextGen At A Crossroads Oct 13
Sheldon Razin Files Definitive Proxy Statement and Sends Letter to Nextgen Healthcare Shareholders Sep 15
Nextgen Healthcare, Inc. Receives Verdict in Favor on All Counts Following Trial Sep 12
Sheldon Razin Provides Information to the Shareholders Aug 28 Sheldon Razin Provides Information to the Shareholders
Consensus forecasts updated Aug 06
First quarter 2022 earnings released: EPS US$0.042 (vs US$0.012 loss in 1Q 2021) Jul 31
Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 44% Undervaluation? Jun 29
NextGen Healthcare, Inc. Affirms Earnings Guidance for the Fiscal Year 2022 Jun 22
President, CEO & Director John Frantz has left the company Jun 22
Independent Vice Chairman notifies of intention to sell stock Jun 04
Consensus forecasts updated Jun 03
Full year 2021 earnings released: EPS US$0.14 (vs US$0.12 in FY 2020) May 29 Shareholder Returns NXGN US Healthcare Services US Market 7D 0.04% -0.1% -0.3% 1Y 19.3% 5.2% 22.7%
See full shareholder returns
Return vs Market: NXGN exceeded the US Market which returned 14.1% over the past year.
Price Volatility Is NXGN's price volatile compared to industry and market? NXGN volatility NXGN Average Weekly Movement 5.2% Healthcare Services Industry Average Movement 11.4% Market Average Movement 6.4% 10% most volatile stocks in US Market 18.8% 10% least volatile stocks in US Market 3.2%
Stable Share Price: NXGN's share price has been volatile over the past 3 months.
Volatility Over Time: NXGN's weekly volatility (5%) has been stable over the past year.
About the Company NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services.
Show more NextGen Healthcare, Inc. Fundamentals Summary How do NextGen Healthcare's earnings and revenue compare to its market cap? NXGN fundamental statistics Market cap US$1.61b Earnings (TTM ) -US$6.21m Revenue (TTM ) US$695.05m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) NXGN income statement (TTM ) Revenue US$695.05m Cost of Revenue US$344.33m Gross Profit US$350.73m Other Expenses US$356.94m Earnings -US$6.21m
Last Reported Earnings
Sep 30, 2023
Earnings per share (EPS) -0.093 Gross Margin 50.46% Net Profit Margin -0.89% Debt/Equity Ratio 63.2%
How did NXGN perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2023/11/11 23:57 End of Day Share Price 2023/11/08 00:00 Earnings 2023/09/30 Annual Earnings 2023/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources NextGen Healthcare, Inc. is covered by 38 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Matthew Gillmor Baird Ishan Majumdar Baptista Research K. Juhng BB&T Capital Markets
Show 35 more analysts 
